Drugs / INCB-9471
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00393120 | Oct 2006 → Sep 2007 | HIV infectious disease | Incyte Corporation | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INCB-9471 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1688243 ↗ |
| Known as | INCB009471 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00393120 ↗ |
| Action | Inhibit | “CCR5 antagonist INCB009471” NCT00393120 ↗ |
| Modality | Small molecule | — CHEMBL1688243 ↗ |
| Target | CCR5 | “CCR5 antagonist INCB009471” NCT00393120 ↗ |